Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

JOINT Corp

JYNT · Nasdaq · CIK 0001612630 · Healthcare · Medical Care Facilities

INSIDER SIGNAL

50.3 / 100

1 buyers · 3 purchase transaction lines · $1.3M gross purchase

WHY THIS SIGNAL?

Buyer breadthLow
Purchase sizeModerate
RoleModerate
RecencyLow
ConvictionStrong
Score anatomy

Each bar shows the contribution to the current score; the weights and formula stay unchanged.

Cluster+7.0 / 35
Purchase size+18.6 / 25
Role+14.0 / 20
Recency+0.7 / 10
Conviction+10.0 / 10

What is holding the score back?

  • ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
  • ⚠ Role scores low · most senior buyer: TenPercentOwner (CEO, chair and 10% owners score lowest)
  • ⚠ Purchase activity is becoming less recent

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
JOBSON CHARLES ETenPercentOwner
●●●
Bowman Scott JustinChief Financial Officer
○
Pant MilindDirector
○
Karrmann Sandra RDirector
○
Grandpre Christopher MDirector
○
DaVella Ronald VDirector
○
● Purchase▼ Sale○ Other

Showing the six most active owners; 1 additional owner(s) remain in Form 4 evidence.

Purchase breadth & concentration

QUALIFYING BUYERS1
PURCHASE CONCENTRATION100%Largest buyer: JOBSON CHARLES E · $1.3M
CLUSTER BUYING · 15D1 insiderPeak activity: 2026-04-21–2026-04-21

Roles in the peak window: TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.

SIGNAL HISTORY

50.3 / 100

Latest recorded score

↓ -0.1 ptsversus the previous recorded snapshot
  1. 50.4
  2. 50.4
  3. 50.5
  4. 50.4
  5. 50.3

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

Recent Form 4 activity

15Purchases
0Sales
8Other Form 4 lines
18SEC filings · 365 days
BUYING3 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER6 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
-12.3%
3M
-24.0%
6M
-19.4%
12M
-19.8%

Volatility & liquidity

Volatility
40.2%
Beta
—
Avg daily value
USD 548,964

Valuation

Market cap
USD 99.6M
P/E
34.2×

Fundamentals

Profit margin
5.3%
ROE
19.3%
Industry
Medical Care Facilities

Market data

Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap, P/E, Profit margin, ROE · Fiscal year ended: 2025-12-31 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-08-03 · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
405,587
Previous report
439,478
Avg daily volume
94,399
Days to cover
4.3

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-05-13JOBSON CHARLES EPurchase (P)Common20,375USD 8.57USD 174,614SEC filing ↗
2026-05-12JOBSON CHARLES EPurchase (P)Common127,676USD 8.57USD 1,094,183SEC filing ↗
2026-04-21JOBSON CHARLES EPurchase (P)Common509USD 8.58USD 4,367SEC filing ↗
2026-02-12JOBSON CHARLES EPurchase (P)Common15,397USD 8.50USD 130,874SEC filing ↗
2026-02-11JOBSON CHARLES EPurchase (P)Common448USD 8.70USD 3,898SEC filing ↗
2026-01-26JOBSON CHARLES EPurchase (P)Common725USD 10.00USD 7,250SEC filing ↗
2026-01-23JOBSON CHARLES EPurchase (P)Common16,753USD 10.00USD 167,530SEC filing ↗
2026-01-06JOBSON CHARLES EPurchase (P)Common5,240USD 8.89USD 46,584SEC filing ↗
2026-01-02JOBSON CHARLES EPurchase (P)Common1,393USD 8.70USD 12,119SEC filing ↗
2025-12-31JOBSON CHARLES EPurchase (P)Common11USD 8.70USD 96SEC filing ↗
2025-12-05JOBSON CHARLES EPurchase (P)Common10,000USD 8.41USD 84,100SEC filing ↗
2025-12-01JOBSON CHARLES EPurchase (P)Common Stock13,000USD 8.41USD 109,330SEC filing ↗
2025-11-25JOBSON CHARLES EPurchase (P)Common Stock2,081USD 8.43USD 17,543SEC filing ↗
2025-11-24JOBSON CHARLES EPurchase (P)Common Stock4,680USD 8.36USD 39,125SEC filing ↗
2025-11-21JOBSON CHARLES EPurchase (P)Common Stock10,000USD 8.50USD 85,000SEC filing ↗

Form 4 evidence

23 transaction lines in the latest 365-day window; 234 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-06-10Bowman Scott JustinTax withholding (F)Common Stock1,392USD 8.43USD 11,735SEC filing ↗
2026-05-20Pant MilindAward / grant (A)Common Stock5,714USD 0.00USD 0SEC filing ↗
2026-05-20Rubel Matthew EAward / grant (A)Common Stock5,714USD 0.00USD 0SEC filing ↗
Show recent Form 4 evidence (23 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-06-10Bowman Scott JustinTax withholding (F)Common Stock1,392USD 8.43USD 11,735SEC filing ↗
2026-05-20Pant MilindAward / grant (A)Common Stock5,714USD 0.00USD 0SEC filing ↗
2026-05-20Rubel Matthew EAward / grant (A)Common Stock5,714USD 0.00USD 0SEC filing ↗
2026-05-20Karrmann Sandra RAward / grant (A)Common Stock5,714USD 0.00USD 0SEC filing ↗
2026-05-20Grandpre Christopher MAward / grant (A)Common Stock5,714USD 0.00USD 0SEC filing ↗
2026-05-20DaVella Ronald VAward / grant (A)Common Stock5,714USD 0.00USD 0SEC filing ↗
2026-05-13JOBSON CHARLES EPurchase (P)Common20,375USD 8.57USD 174,614SEC filing ↗
2026-05-12JOBSON CHARLES EPurchase (P)Common127,676USD 8.57USD 1,094,183SEC filing ↗
2026-04-21JOBSON CHARLES EPurchase (P)Common509USD 8.58USD 4,367SEC filing ↗
2026-03-09Razdan Sanjiv KumarAward / grant (A)Common Stock73,484USD 0.00USD 0SEC filing ↗
2026-03-09Bowman Scott JustinAward / grant (A)Common Stock28,301USD 0.00USD 0SEC filing ↗
2026-02-12JOBSON CHARLES EPurchase (P)Common15,397USD 8.50USD 130,874SEC filing ↗
2026-02-11JOBSON CHARLES EPurchase (P)Common448USD 8.70USD 3,898SEC filing ↗
2026-01-26JOBSON CHARLES EPurchase (P)Common725USD 10.00USD 7,250SEC filing ↗
2026-01-23JOBSON CHARLES EPurchase (P)Common16,753USD 10.00USD 167,530SEC filing ↗
2026-01-06JOBSON CHARLES EPurchase (P)Common5,240USD 8.89USD 46,584SEC filing ↗
2026-01-02JOBSON CHARLES EPurchase (P)Common1,393USD 8.70USD 12,119SEC filing ↗
2025-12-31JOBSON CHARLES EPurchase (P)Common11USD 8.70USD 96SEC filing ↗
2025-12-05JOBSON CHARLES EPurchase (P)Common10,000USD 8.41USD 84,100SEC filing ↗
2025-12-01JOBSON CHARLES EPurchase (P)Common Stock13,000USD 8.41USD 109,330SEC filing ↗
2025-11-25JOBSON CHARLES EPurchase (P)Common Stock2,081USD 8.43USD 17,543SEC filing ↗
2025-11-24JOBSON CHARLES EPurchase (P)Common Stock4,680USD 8.36USD 39,125SEC filing ↗
2025-11-21JOBSON CHARLES EPurchase (P)Common Stock10,000USD 8.50USD 85,000SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerJYNT
CIK0001612630
SectorHealthcare
IndustryMedical Care Facilities Yahoo Finance
SEC SIC6794 Patent Owners & Lessors
ExchangeNasdaq

Data coverage

Local Form 4 history234 transaction lines from 2020-03-03 to 2026-06-10
99 P purchase lines · 68 S sale lines · 67 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.